The QualityStocks Daily Monday, June 12th, 2023

Today's Top 3 Investment Newsletters

QualityStocks(AUUD) $1.2200 +181.50%

MarketClub Analysis(ASST) $2.0200 +75.65%

Schaeffer's(KDNY) $37.9800 +58.32%

The QualityStocks Daily Stock List

Auddia (AUUD)

MarketClub Analysis, QualityStocks, MarketBeat and BUYINS.NET reported earlier on Auddia (AUUD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Auddia Inc. (NASDAQ: AUUD) is a technology firm that is engaged in the development of software products for the podcast and audio markets as well as in the provision of digital music solutions.

The firm has its headquarters in Boulder, Colorado and was incorporated in 2011 by Jeffrey J. Thramann. Prior to its name change in November 2019, the firm was known as Clip Interactive LLC. The firm operates in the technology sector, under the software and tech services industry and serves consumers in the U.S. It generates its revenue via subscription fees from consumers who access its cloud-based computing and advertisement services.

The enterprise is currently engaged in the development of an artificial intelligence-based software technology for consumers and firms in audio media. The technology will allow individuals to tune in to AM/FM radio stations without commercials. It has been designed to identify the differences between a song and a commercial and is working on distinguishing between other content, like DJ conversations, sports, news, traffic and weather reports, among others.

The company’s products include an interactive platform for podcasting known as Vodacast, which podcasters can use to allow their listeners to view video via a digital feed that corresponds to their podcast audio. In addition to this, the company also provides a subscription-based commercial-free AM/FM software application dubbed Auddia App.

The firm recently announced that it had made major advancements in its AI-based software technology. This technology is expected to boost the overall performance of the company’s platform and also positively impact user experience, which will encourage more investments into the firm, thus boosting its growth.

Auddia (AUUD), closed Monday's trading session at $1.22, up 181.4951%, on 147,463,967 volume. The average volume for the last 3 months is 4.942M and the stock's 52-week low/high is $0.38/$1.75.

Sonnet BioTherapeutics Holdings (SONN)

QualityStocks, StockMarketWatch, MarketBeat, BUYINS.NET, The Stock Dork, The Online Investor, OTCtipReporter and InvestorsUnderground reported earlier on Sonnet BioTherapeutics Holdings (SONN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) is a clinical-stage biotechnology firm that is engaged in the development of a platform for biologic drugs for bispecific or single action.

The company, which has its headquarters in Princeton, New Jersey, was incorporated in 2011. It operates as a part of the biotechnology product manufacturing industry and serves consumers in the United States.

The firm develops FHAB technology (fully human albumin binding), which uses single chain antibodies that bind themselves to human serum albumin to target tissues. Its FHAB construct also amasses naturally at inflammation sites, such as tumors, consequently increasing delivery to target tissues. The technology is well suited for drug development across various human disease areas, which include hematological, inflammatory, pathogenic, autoimmune and oncological conditions.

The enterprise’s product pipeline comprises of a bi-specific anti-IL6 (Interleukin-6) and anti-tumor growth candidate dubbed SON-3015, for bone and tumor metastases; a bispecific combination of Interleukin-18 termed SON-2014, indicated for cancer treatment; a bispecific construct which combines their FHAB technology with human Interleukin-15 and IL-12 termed SON-1210, which has been indicated for solid tumor treatment; a candidate currently in phase 1 trials developed for patients with diabetic peripheral neuropathy dubbed SON-081; a low dose IL-6 which recently concluded phase 1 trials for treating patients with peripheral neuropathy which was induced by chemotherapy dubbed SON-080 and SON-1010.

The firm recently entered into a definitive agreement with New Life Therapeutics Ltd, for the license of their IL-6 diabetic peripheral neuropathy. This move not only alleviated some of the development burden of the firm but will also allow them to reach into territories with compelling commercial market dynamics, which will be good for the company’s growth and revenue.

Sonnet BioTherapeutics Holdings (SONN), closed Monday's trading session at $0.601, up 21.9067%, on 5,043,205 volume. The average volume for the last 3 months is 1.026M and the stock's 52-week low/high is $0.205/$4.48.

Finch Therapeutics (FNCH)

MarketBeat, QualityStocks and FreeRealTime reported earlier on Finch Therapeutics (FNCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Finch Therapeutics Group Inc. (NASDAQ: FNCH) is a clinical-stage microbiome therapeutics firm that is focused on the development of new orally administered biological medications for the treatment of various indications.

The firm has its headquarters in Somerville, Massachusetts and was incorporated in 2014 by Zain Kassam, Tom Borody, Andrew Noh and Mark Smith. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company is party to collaboration and license agreements with the University of Minnesota; Skysong Innovations LLC; and Takeda Pharmaceutical Company Ltd. It is focused on delivering microbial therapies to patients with unmet medical needs.

The enterprise’s product pipeline is comprised of orally administered formulations, FIN-525 and TAK-524, which target consortia product candidates for the treatment of Crohn’s disease and ulcerative colitis. It also develops an enriched consortia formulation which is orally administered and is dubbed FIN-211, to help treat autism spectrum disorder. In addition to this, the enterprise is involved in the development of an orally administered microbiome capsule known as CP101, which is undergoing phase III clinical trials for the treatment of chronic Hepatitis B virus. This formulation is also being developed for the treatment of Clostridioides difficile infection.

The firm is currently focused on executing its strategic objectives, which include advancing its Autism spectrum disorder and Clostridioides difficile infection programs. The success of these programs will help deliver on the firm’s mission to serve patients. This is in addition to boosting the firm’s revenues and benefiting its shareholders.

Finch Therapeutics (FNCH), closed Monday's trading session at $11.5, up 4143.54%, on 1,039,200 volume. The average volume for the last 3 months is 240 and the stock's 52-week low/high is $7.515/$90.00.

Playmates Holdings (PYHOF)

We reported earlier on Playmates Holdings (PYHOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Playmates Holdings Limited (OTC: PYHOF) (HKG: 0635) (FRA: PLJ2) is an investment holding firm that is focused on creating, designing, developing, marketing and distributing toys.

The firm has its headquarters in Tsim Sha Tsui, Hong Kong and was incorporated in 1966. It operates as part of the leisure industry, under the consumer cyclical sector. The firm serves consumers around the globe, with a focus on those in Hong Kong, the Americas, the rest of the Asia Pacific and Europe.

The enterprise, which has a heritage of numerous successful brands and a history of over 40 years, operates through the Property Investments and Associated Businesses; Investment Business; and Toy Business segments. The Property Investments and Associated Businesses segment is focused on investing in and leasing industrial, commercial and residential premises for rent. This is in addition to offering property management services, such as building security, repair and maintenance, general cleaning for common areas, hand-over and take-over of premises, and the monitoring of reinstatement and refurbishment works. Further, it engages in building management business activities to provide value enhancement services for its principal investment properties. It currently holds a portfolio of investment properties for retail, commercial, industrial and residential use with a total gross area of about 500,000 ft2. On the other hand, the Investment Business segment invests in financial instruments, including listed equity and managed funds. The Toy Business segment is involved in designing, developing, marketing and distributing toys and family entertainment activity products.

The company remains committed to generating value for its stakeholders and bolstering its overall growth.

Playmates Holdings (PYHOF), closed Monday's trading session at $0.0783, even for the day. The average volume for the last 3 months is 29,314 and the stock's 52-week low/high is $0.0698/$0.0875.

Lithium Chile (LTMCF)

QualityStocks, NetworkNewsWire, StocksToBuyNow,, SeriousTraders and InvestorPlace reported earlier on Lithium Chile (LTMCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lithium Chile Inc. (OTC: LTMCF) (CVE: LITH) (FRA: KC3) is a firm focused on acquiring and developing lithium properties in Argentina and Chile.

The firm has its headquarters in Calgary, Canada and was incorporated in 2010, on October 18th. Prior to its name change in December 2017, the firm was known as Kairos Capital Corp. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm primarily serves clients in Canada.

The company holds high-grade lithium reserves comprising of approximately 110,000 hectares in Chile and 20,800 hectares in Argentina. Its lithium projects include Salar de Arizaro, Salar de Coipasa, Salar de Helados, Salar de Laguna Blanca, Salar de Atacama, and Salar de los Morros. A Phase II Exploration & Development Program is currently underway in Arizaro, Argentina to expand the resource of 2.58 million tons (LCE) as reported in their 43-101 technical report. An Exploration Program in Chile on 3 key properties, with historical drill results showing high grade lithium, kicked off in the second quarter of 2023. The company also explores for silver, gold and copper deposits. Its gold projects include Carmona and Apolo/Sancarron. Overall, the company owns 5 properties totaling roughly 22,429 hectares, which are prospective for gold, silver and copper.

The enterprise, which has one of the top lithium exploration portfolios globally, remains focused on expanding lithium production. This will, in turn, drive revenues and investments into the enterprise while also creating value for its shareholders.

Lithium Chile (LTMCF), closed Monday's trading session at $0.66777, off by 3.6685%, on 29,314 volume. The average volume for the last 3 months is 1,300 and the stock's 52-week low/high is $0.325/$0.8089.

Ramelius Resources (RMLRF)

We reported earlier on Ramelius Resources (RMLRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ramelius Resources Limited (OTC: RMLRF) (ASX: RMS) (FRA: RRZ) is a gold exploration and production firm focused on exploring for, developing and operating mines, as well as producing and selling gold.

The firm has its headquarters in East Perth, Australia and was incorporated in 1979, on May 4th. It operates as part of the gold industry, under the basic materials sector. The firm serves clients around the globe, with a focus on those in Australia.

The company operates through the Mt. Magnet, Edna May and Exploration segments. It owns and operates the Mt Magnet Gold Mine, the Penny Gold Mine, the Vivien Gold Mine, the Edna May Gold Mine, the Marda Gold Mine, the Tampia Gold Mine, the Rebecca Gold Project and Lake Roe Gold Project around Western Australia. The Mt Magnet gold project is located roughly 500 km north-east of Perth in the Murchison Goldfield of the Western Australian Yilgarn Craton. The Penny Gold Mine is located about 550 km north-east of Perth in Western Australia. The Vivien Gold Mine is located nearly 15 km west of the town of Leinster in Western Australia. The Edna May Gold Mine is located within the Westonia Greenstone Belt, within the Southern Cross Province of Western Australia’s Archaean Yilgarn Craton. The Lake Roe Gold Project is located more than 100 km east of Kalgoorlie, Western Australia. The company generates most of its revenue from the Mt. Magnet Goldmine project.

The enterprise remains focused on delivering superior returns for its shareholders via sustainable gold production.

Ramelius Resources (RMLRF), closed Monday's trading session at $0.9535, even for the day. The average volume for the last 3 months is 600 and the stock's 52-week low/high is $0.3828/$0.9962.


We reported earlier on SDI Group (SDIIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SDI Group PLC (OTC: SDIIF) (LON: SDI) (SWX: KGX) (BMV: KGXN) (ETR: KGX) is a company focused on designing and manufacturing scientific and technology products based on digital imaging in the United Kingdom, Asia, the United States and the rest of Europe.

The firm has its headquarters in Cambridge, the United Kingdom and was incorporated in 2007. Prior to its name change in November 2019, the firm was known as Scientific Digital Imaging Plc. It operates as part of the scientific and technical instruments industry, under the technology sector. The firm serves consumers around the globe.

The enterprise operates through the Digital Imaging; and Sensors & Control segments. It provides cameras for art conservation under the Opus Instruments brand name; sensitive camera for life science and industrial applications under the Atik Camera brand name; and cameras that have applications in astronomy and life science fields under the Quantum Scientific Imaging brand name. It also supplies chemical dosing and control system for manufacturing industries; and provides precision re-circulating chiller, cooler, and heat exchangers to control the thermal environment. This is in addition to offering system and software for automated gel-based DNA and protein fluorescence/chemiluminescence imaging under the G:BOX and NuGenius brands; AutoCOL, which develops and manufactures a range of automated colony counting and zone sizing product; and ProtoCOL 3, a system that is used for vaccine and antibiotic development in pharmaceutical firms.

The company remains committed to advancing its vision of developing and diversifying its existing technologies and growing through strategic acquisitions, which may positively influence shareholder value.

SDI Group (SDIIF), closed Monday's trading session at $1.7, even for the day. The average volume for the last 3 months is 2,800 and the stock's 52-week low/high is $1.65/$2.5839.

TCL Electronics (TCLHF)

We reported earlier on TCL Electronics (TCLHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

TCL Electronics Holdings Limited (OTC: TCLHF) (HKG: 1070) (SHE: 000100) (FRA: TC2A) is an investment holding firm that operates as a consumer electronics firm focused on manufacturing televisions and display products.

The firm has its headquarters in Sha Tin, Hong Kong and was incorporated in 1999 by Li Dongsheng. Prior to its name change, it was referred to as TCL Multimedia Technology Holdings Ltd. It operates as part of the consumer electronics industry, under the technology sector. The firm serves consumers globally, with a focus on those in the People’s Republic of China, North America and Europe.

The enterprise operates as a TCL Technology Group Corp subsidiary, through the Smart Screen; Internet Business; Smart Mobile, Connective Devices and Service; All-Category Marketing; and Smart Commercial Display, Smart Home, Photovoltaic and Other Businesses segments. It manufactures and sells television sets, smartphones, smart connective devices, smart commercial display and smart home products, and photovoltaic equipment. The enterprise also engages in membership cards, video-on-demand, advertising, vertical application, and other businesses. This is in addition to distributing TCL branded air conditioners, refrigerators and washing machines, and other household appliances. Further, the enterprise is involved in trading TV products and components, and white goods; research and development of software on smart TV devices, and mobile devices; operation of an internet platform; and distribution of mobile devices and components.

The company recently launched its latest multi-category products for the Middle East and Africa (MEA) market at an exclusive launch event in Dubai, a move that will extend its reach while also opening it up to new growth and investment opportunities.

TCL Electronics (TCLHF), closed Monday's trading session at $0.4337, even for the day. The average volume for the last 3 months is 850,387 and the stock's 52-week low/high is $0.3425/$0.6757.

HIVE Blockchain Technologies Ltd. (HIVE)

QualityStocks, InvestorPlace, MarketClub Analysis, MarketBeat, StreetInsider, Early Bird, StockMarketWatch,, CryptoCurrencyWire, Greenbackers, Hit and Run Candle Sticks, Barchart, Stock Market Watch, WealthMakers, StockOodles, StreetAuthority Daily, The Night Owl, The Online Investor, TopStockAnalysts, Wall Street Resources and smartOTC reported earlier on HIVE Blockchain Technologies Ltd. (HIVE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Swift, the messaging system used for interbank communication, and Chainlink (LINK), a supplier of blockchain real-world data, have announced a collaborative effort with numerous financial institutions. The objective of this initiative, as outlined in a press release released last week, is to explore how these institutions can establish connections with various blockchain networks.

In a series of tests, Swift will join forces with prominent traditional financial organizations such as the DTCC, ANZ, Citi, BNY Mellon, BNP Paribas, Euroclear and Clearstream. The primary aim is to evaluate the feasibility of utilizing Swift’s innovations to facilitate the exchange of tokenized assets between different blockchains.

This proof-of-concept project has been devised to demonstrate the practicality of interoperability between private and public networks. The testing will initially focus on asset transfers on the Sepoliatestnet of Ethereum, which connects the Ethereum mainnet to a permissioned blockchain. The collaboration will also examine transfers between Ethereum and other public networks.

To facilitate these experiments, Chainlink will offer interoperability between private and public blockchains. The partnership between Swift and Chainlink was initially unveiled at Chainlink’s yearly conference: SmartCon.

This collaboration not only holds significance for banking institutions but also signifies a crucial milestone for the cryptocurrency industry, as emphasized by Sergey Nazarov, cofounder of Chainlink. Nazarov highlighted the global capital held by banks and expressed the belief that the industry’s growth beyond trillions of dollars will be driven by the participation of banks and their customers in the blockchain sector.

This development underscores the increasing interest of institutional players in integrating customer requirements through public and permissioned blockchain networks such as Ethereum, said Swift’s head of securities strategy, Jonathan Ehrenfeld.

The potential inclusion of public blockchains by Swift could have a profound impact on the Web3 sector. Swift acknowledged that blockchain-enabled operational efficiencies have the potential to attract more players to the private markets, consequently enhancing liquidity.

According to the Financial Times’ estimation, Swift handled over one-half of all international cross-border transactions in 2018. The paper also noted Swift’s flaws, pointing out that its transactions were time-consuming, expensive and opaque as to the total amount of money received.

This joint effort between Swift, Chainlink and major financial institutions may pave the way for optimizing various types of securities for public chains, addressing the growing acceptance of digital assets. Currently, the total market capitalization of the cryptocurrency market stands at $1.08 trillion, according to CoinMarketCap data, further indicating the increasing importance of these initiatives.

Major industry actors such as HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) (TSX.V: HIVE) will likely be pleased that Swift and Chainlink are working together to make the broader penetration of blockchain technologies possible in the general financial system.

HIVE Blockchain Technologies Ltd. (HIVE), closed Monday's trading session at $3.1, up 3.3333%, on 851,073 volume. The average volume for the last 3 months is 33.674M and the stock's 52-week low/high is $1.36/$7.525.

Rivian Automotive Inc. (RIVN)

InvestorPlace, Kiplinger Today, The Street, Schaeffer's, QualityStocks, MarketBeat, Early Bird, Investopedia, MarketClub Analysis, The Online Investor, StockEarnings, Daily Trade Alert, StocksEarning, Zacks, The Night Owl, Trades Of The Day, Louis Navellier, InvestorIntel, AllPennyStocks, TipRanks, INO Market Report, InvestorsUnderground, Top Pros' Top Picks and Cabot Wealth reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A study by the American Lung Association projects that almost 90,000 lives might be saved by 2050 through the adoption of electric vehicles in the United States. However, in order to realize the entire benefits of health, the nation would also need to move further toward cleaner, noncombustion energy sources, including geothermal, wind, hydro and solar.

The study estimates that moving to cleaner cars and better energy sources will result in 2.2 million fewer instances of asthma and 10.7 million fewer lost working days will be lost. In addition, the American healthcare system will benefit by saving $978 billion.

According to the U.S. Environmental Protection Agency, the transport sector is the primary contributor to emissions of carbon, which is what is causing the environmental crisis and is America’s worst source of air pollutants. Being exposed to any form of pollution is harmful to human health; research has shown that pollution dramatically increases the risk of dying young or developing chronic diseases such as asthma, heart issues, Alzheimer’s disease or depression.

Research released this year by the American Lung Association revealed that almost 120 million Americans reside in places with poor air quality. Communities with low incomes and those of color suffer the most from this health issue. According to studies, groups in these categories frequently reside closer to significant sources of air pollutants, such as power stations and busy highways.

According to Dr. Jason West, the transition to EVs would entail an initial expenditure; however, the enormous benefits of health may well outweigh the initial costs of the said activities. The automobile sector as a whole and the government at large are making major efforts to speed the transition to vehicles with no emissions.

In an effort to minimize pollution from all sides, the American government has been pressing for tighter regulations regarding car emissions as well as stringent restrictions on the emissions of the energy industry. The Environmental Protection Agency reinstated the Obama-period auto-emissions standards in 2021, and the agency released a proposal in April that would impose even tighter emissions regulations on all vehicles and light-duty trucks. The U.S. EPA has also suggested regulations that could impose stricter restrictions on emissions that contribute to ozone formation, carbon and pollution from particulates.

Congress has made efforts to reduce pollution as well. Last year’s IRA provided a tax credit of $7,500 that runs up to August 2032 for the acquisition of an EV, thus encouraging Americans to acquire emission-free automobiles.

Many automakers are making efforts to produce greener vehicles. More alternatives are available than before, and both range and battery power have significantly increased. The future is expected to see more advancements in this area. The majority of automakers intend to release a number of new vehicles in the next 10 years and are making billion-dollar investments in the construction of factories to produce batteries and advance EV technology.

As all those expansion projects start bringing EVs onto the market, the competition between the various manufacturers such as Rivian Automotive Inc. (NASDAQ: RIVN) and rivals from around the world may reach high levels, to the benefit of consumers.

Rivian Automotive Inc. (RIVN), closed Monday's trading session at $14, up 0.937275%, on 33,828,264 volume. The average volume for the last 3 months is 196,017 and the stock's 52-week low/high is $11.68/$40.86.

Mind Medicine Inc. (MNMD)

QualityStocks, InvestorPlace, Schaeffer's, The Wealth Report, The Street, MarketBeat, The Stock Dork, MarketClub Analysis, Daily Trade Alert and Trades Of The Day reported earlier on Mind Medicine Inc. (MNMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lawmakers in Nevada have approved a bill that would create a psychedelic working group to study hallucinogenics and aid in the development of a therapeutic psychedelic market in the state. Recent efforts by scientists across the country have shown that psychedelics, long considered by federal law as controlled drugs with zero medical application, may be able to alleviate a wide variety of mental health disorders.

Researchers have found that when paired with talk therapy, even a single dose of a psychedelic such as psilocybin can offer patients sustained and long-term relief against the symptoms of conditions such as treatment-resistant depression and post-traumatic stress disorder (PTSD). Nevada now joins the growing number of regions that have either passed some kind of psychedelics regulations or are considering joining the young but swiftly growing industry.

The state legislature passed the psychedelics bill in a unanimous vote and sent it to the governor’s desk for his consideration and signature. Introduced by Senator Rochelle Nguyen, the measure would have originally expanded the scope of psychedelic research in Nevada as well as legalized psilocybin, the main psychoactive agent in magic mushrooms.

However, the measure was scaled back by the Senate to focus solely on creating a psychedelic medicines working group charged with investigating the therapeutic, medicinal and wellness potential of entheogens. Entheogens include psychedelics such as psilocybin, ayahuasca and peyote, which are derived from naturally occurring fungi and plants.

Nguyen noted earlier that her bill would most likely be amended and said that she did not mind any changes; she  simply wanted to get the legislature talking about psychedelic reform.

If the bill is signed into law, it will result in the formation of a 15-member working group under the auspices of the Nevada Department of Health and Human Services (HHS). The members would include the director of HSS, the state attorney general, the president of the Nevada Board of Pharmacology, and the director of veteran services.

The working group will be in charge of investigating the therapeutic potential of hallucinogenics, including but not limited to psilocin and psilocybin, in overall wellness and against mental disorders such as substance use disorder, major depressive disorder and PTSD.

Additionally, the working group would be tasked with analyzing local, state and federal laws on the medical use of psychedelics and coming up with an actionable plan for how Nevada can allow access to safe, affordable and effective entheogens.  The group would also have to compile its findings into a report and submit that report to the state legislature by Dec. 31, 2024.

The working group created in Nevada could benefit from some of the scientific data that enterprises such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) have documented regarding the therapeutic potential of a number of hallucinogens.

Mind Medicine Inc. (MNMD), closed Monday's trading session at $3.72, up 1.6393%, on 197,325 volume. The average volume for the last 3 months is 698,221 and the stock's 52-week low/high is $2.12/$19.95.

Southern Copper Corporation (SCCO)

MarketBeat, SmarTrend Newsletters, InvestorPlace, The Street, Louis Navellier, QualityStocks, The Online Investor, Daily Wealth, The Wealth Report, Daily Trade Alert, TopStockAnalysts, Trades Of The Day, StreetAuthority Daily, Zacks,, Barchart, Early Bird, Money Morning, TheStockAdvisor, Market Intelligence Center Alert, Schaeffer's, Kiplinger Today, Investopedia, Market Authority, MarketClub Analysis, The Growth Stock Wire, Uncommon Wisdom, DividendStocks, Top Pros' Top Picks, TheStockAdvisors, StreetInsider, The Stock Enthusiast, Investment House, Market Report, ChartAdvisor, InvestmentHouse, AllPennyStocks, BestOtc, Cabot Wealth, CRWEFinance, Dividend Opportunities, Investing Futures, CRWEPicks, Greenbackers, Forbes, CRWEWallStreet, DrStockPick, Investiv, StockLockandLoad, Wealth Insider Alert, Wealth Daily, Vantage Wire, TradingMarkets, TradingAuthority Daily, TradersPro, The Tycoon Report, The Trading Report, The Motley Fool, MarketDNA, StockRockandRoll, Investor Update, StockHotTips, Profit Confidential, PennyToBuck, PennyOmega, Navellier Growth, Money and Markets, 24/7 Trader, InvestorsObserver Team, InvestorIntel, InvestorGuide and Streetwise Reports reported earlier on Southern Copper Corporation (SCCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

For the past few months, mining experts have warned that there isn’t enough copper to sustain global industrial needs. Higher demand coupled with constrained supply from South America has exacerbated an ongoing copper shortage that experts predict could last for the rest of the decade.

Slower projections of growth in China, which is the global leading importer of copper ore, coupled with higher interest rates, and a banking crisis in the United States have also dampened copper’s outlook for the year. Since copper plays a critical role in industrial machinery and electrical equipment, products largely responsible for keeping our economies up and running, it is often seen as an indicator of economic health at a set time.

The red metal will be especially crucial to the green-energy transition because it is a critical component in electric vehicles and EV charging infrastructure.

Despite predictions of increased short-term challenges, the copper industry has incredible potential for growth over the long term. Countries such as the U.S. have already begun investing billions of dollars into building EVs and developing EV infrastructure. Furthermore, wind and solar energy, which are expected to replace fossil fuels over the next few decades, rely on copper for wiring because it is extremely conductive and has a high corrosion resistance.

Investors who focus on short-term predictions and avoid copper may lose significant windfalls they could have made in the long-term once the copper market corrects itself and supply becomes sufficient enough to meet the increasing demand.

A look back at copper prices in the aftermath of the coronavirus pandemic, around March 2020, shows that copper futures sank to historically low prices as a stock market panic resulted in a major sell-off of global equities. Sine then, copper prices steadily increased through 2020 and 2021 to achieve an all-time high of more than $10,700 per ton in March 2022, signifying the metal’s extreme resilience in the face of major roadblocks.

Although copper prices have since fallen from these highs, the metal has managed to remain on an upward trajectory over the long-term despite a global recession, increasing interest rates across the world and lockdowns in the major copper importer China.

Copper has maintained its long-term upward trajectory amid a multitude of opposing factors and short-term volatility. The red metal will most likely maintain that upward growth due to its importance in economies, and investors who ignore the short-term volatility currently plaguing the industry stand to gain massive copper investment opportunities in the future.

Some of those opportunities could come through doing due diligence and acquiring stocks in leading firms, such as Southern Copper Corporation (NYSE: SCCO), if one is satisfied by what they discover when they study the financial books and reports of these extraction companies.

Southern Copper Corporation (SCCO), closed Monday's trading session at $70.53, off by 1.0522%, on 712,017 volume. The average volume for the last 3 months is 55,499 and the stock's 52-week low/high is $42.42/$82.05.

The QualityStocks Company Corner

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

NetworkNewsAudio – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) announces the availability of a broadcast titled, "The Supply Crisis for Rare Earth Elements Intensifies."

To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast

To view the full editorial, please visit:

For more than 15 years, Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) has been an important part of the rare earth market, developing technology to disrupt the status quo of rare earth elements. The company is now in a position to help solve the impending supply crisis by assisting with the creation of an independent supply chain of rare earth oxides for North American manufacturers. Ucore has differentiated itself with a unique approach that focuses on the most profitable sector of the supply chain, processing material and avoids the risks of large CAPEX requirements.

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX™, for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. Its initial focus is on processing heavy and light rare earth elements (“REEs”), disrupting a supply chain that is dominated by China.

China currently controls about 80% of the world’s access to REE mining projects and over 90% of the world’s REE processing capabilities, and it produces about 95% of the goods containing REE components.


Ucore is working to scale Western supply needs by establishing REE separation and rare earth oxide (“REO”) production capabilities in cooperation with strategic upstream supply and downstream offtake partnerships. The company, along with its industry partners, aims to unlock access to Western REEs for current consumer, energy, manufacturing and military sectors.

By 2025, Ucore expects to commercially separate U.S.-friendly sources of REEs and supply OEMs with REOs required to produce rare earth permanent magnets (“REPMs”) – the essential component of electric motors and generators required to support the world’s transition to electrification and sustainable energy sources.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

The company has three initial U.S.-friendly feedstock agreements in place for the Louisiana complex, along with multiple developing offtake agreements. It received a C$16 million+ incentive package offer from Louisiana Economic Development to support construction of the SMC.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Monday's trading session at $0.911, up 7.8107%, on 55,499 volume. The average volume for the last 3 months is 14,027 and the stock's 52-week low/high is $0.40/$1.15.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of a new chief financial officer. Effective immediately, Mike Shankman will serve as outsourced CFO. An experienced accounting and finance professional, Shankman has held senior positions with companies in the biotechnology, medical devices and software-as-a-service industries. As a consultant with NOW CFO, one of his current clients is a publicly traded clinical-stage biopharmaceutical company. Former clients include a medical device maker for which Mike collaborated with independent auditors and investment bankers through the completion of an initial public offering. The client began trading on the NASDAQ in 2022.

To view the full press release, visit

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Monday's trading session at $0.754, up 1.4259%, on 14,247 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.15/$.

Recent News

Fintech Ecosystem Development Corp. (NASDAQ: FEXD)

The QualityStocks Daily Newsletter would like to spotlight Progressive Care Inc. (OTCQB: FEXD).

Fintech Ecosystem Development seeks to offer a diverse portfolio of fintech-related products and services to consumers and businesses in Europe, South Asia, East Asia, Latin America, Africa, and the United States

The company is looking to participate in the growing cashless payments space, where global payment transaction volumes are set to increase by almost 300% by 2030

FEXD intends to acquire or merge with pioneering fintech companies with, among others, a large customer base and the potential to be scaled up to global markets

By executing its growth strategy, the company looks to equip cashless societies with scalable access to payment technologies and solutions

Consumers around the world were embracing cashless payments even before the COVID-19 pandemic broke out, from tapping a sales terminal with a mobile phone in the U.S. to making QR code payments in China. As a result, professional services multinational PWC writes in a report that this shift from cash payments "might ultimately lead to a cashless global society." In fact, their analysis shows that the global cashless payment volumes are set to increase from about 1 trillion transactions in 2020 to almost 1.9 trillion in 2025, representing a jump of over 80%. By 2030, it is anticipated that the volume will have shot up to almost 3 trillion, a three-fold increase (

Emerging markets in the Asia-Pacific region and Africa are set to witness the fastest growth. "Asia-Pacific will grow fastest, with cashless transaction volume growing by 109% until 2025 and then by 76% from 2025 to 2030, followed by Africa (78%, 64%) and Europe (64%, 39%)," the report continues. These projections align with the most recent data from Southeast Asia compiled by the Thai office of multinational VISA Inc. (NYSE: V) ( Here, according to VISA, "93% of consumers use a multitude of cashless payment methods including cards, contactless cards and mobile contactless, mobile wallets, and QR code payments."

Fintech Ecosystem Development (NASDAQ: FEXD), a company looking to develop a global financial technology ecosystem, with plans to offer a diverse portfolio of fintech-related products and services to consumers and businesses in Europe, South Asia, East Asia, Latin America, Africa, and the United States, is eyeing a share of this growth.

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a special purpose acquisition company (SPAC) formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector.

The company’s mission is to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. FEXD plans to achieve this by acquiring and merging with financial technology pioneers that have the potential to help establish its global fintech ecosystem, and by continuing the development of proprietary technologies and applications to keep the company at the forefront of the cashless society market.

Digital money is replacing physical cash. Consumers can buy products and services from anywhere in the world and make payments across borders. Parents can send money to students studying in other countries. Migrant workers are sending money to families in developing nations. Rural villagers without banks can send and receive money using their smartphones. FEXD is developing mobile transaction platforms, applications and services that are helping to implement these changes.

The company plans to offer a diverse portfolio of products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, Europe and Latin America. Its growth strategy includes acquisition, innovation and market development.

FEXD is a Delaware corporation based in Collegeville, Pennsylvania. The company was launched in May 2021 by a management team led by Dr. Saiful Khandaker that has extensive experience in developing and managing financial service platforms and applications, primarily in the mobile money sector. FEXD is sponsored by Revofast LLC.

Acquisition Targets

In September 2022, FEXD announced definitive agreements for business combinations with Rana Financial Inc., a Georgia corporation, and Mobitech International LLC (dba Afinoz), a limited liability company organized in the United Arab Emirates. The agreements call for Rana and Afinoz to become wholly owned subsidiaries of FEXD, with the combined company expected to continue trading on the Nasdaq under existing ticker symbol ‘FEXD’. The mergers are expected to close in Q2 2023.

Rana Financial

Rana Financial is a licensed money transfer company founded in 2009. Rana provides fast and affordable online and mobile transfer of funds between the U.S. and Latin America. Rana has been providing money transfer services in the U.S. market for 13 years and has 30,000 active users. Rana’s money transfer business grew to 200,000 transactions in 2021. The merger agreement values Rana at an implied $78 million enterprise value.

Mobitech International LLC

Mobitech International LLC (dba Afinoz) is an artificial intelligence-enabled digital lending platform used by India’s leading banks, non-banking financial companies and fintech loan providers. Afinoz’s fintech platform supports enterprises making loans primarily to middle- and working-class borrowers via its website or through its mobile phone application. Afinoz’s platform makes loans available and affordable to millions of Indian workers and unbanked users by providing access at a low cost. Afinoz’s platform has more than 50 lending partners, and its database of registered users in India includes more than two million individuals. The merger agreement values Afinoz at an implied $120 million enterprise value.

Market Opportunity

According to analysis by global market research firm Mordor Intelligence, the worldwide financial technology market is valued at approximately $194 billion in 2023 and is projected to grow to nearly $500 billion by 2028, representing a CAGR of 18.97% for the forecast period. According to the report, various financial crises and the COVID-19 pandemic have fueled consumer adoption of, and investor interest in, fintech over the past several years.

Management Team

Dr. Saiful Khandaker is Founder, CEO and President of FEXD. He is Group CEO and founder of FAMA Holdings Inc., a global developer of fintech platforms, applications and services based in the U.S. with offices in the U.K., India, Bangladesh and Zambia. He is currently leading the development of the FAMACASH™ network, a global fintech ecosystem to provide fast, affordable mobile money services in underserved countries such as Bangladesh. Before founding FAMA, Dr. Khandaker spent more than two decades leading the development of software solutions for Fortune 100 companies and startups. He also helped numerous clients modernize their fintech services as Chief Technology Officer at Mi3. He holds a Doctor of Management in Organizational Leadership, a Master of Science in Technology Management, and a Bachelor of Science in Computer Information Systems.

Jenny Junkeer is CFO at FEXD. She is a Chartered Accountant with over 17 years of experience. As CEO of Junkeer New Era Consulting, she leads a team specializing in helping companies launch and optimize business operations in fast-changing industries. She has extensive experience helping organizations scale operations to maximize value. She is an Adjunct Association Professor at Deakin University in Australia, a board member of the Global Health Initiative Foundation, and Director of Implementation at ConnectCV. She holds a Bachelor of Commerce Degree (Honors) from Monash University.

FingerMotion Inc. (FEXD), closed Monday's trading session at $10.5799, even for the day, on 4 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $9.9701/$11.00.

Recent News

Starco Brands Inc. (OTCQB: STCB)

The QualityStocks Daily Newsletter would like to spotlight Starco Brands Inc. (OTCQB: STCB).

Fragrance allergies affect 2M+ people across the US, symptoms include skin redness, burning sensations, eyelid tearing, and swelling

Skylar hypoallergenic fragrance line offers a safe alternative that doesn't contain any of the 36 known allergens or 1,300+ "questionable" ingredients found in most fragrances

Starco Brands recently released Skylar's "Boardwalk Delight" scent at Sephora, sells out after 10 days

All 10 Skylar scents are available at 500+ Sephora retail locations and online

Fragrance allergies affect more than 2 million Americans, with symptoms that include skin redness, burning sensations, eyelid tearing, and swelling. Even simple sensitivities can trigger reactions like headaches, breathing difficulties, sneezing, and nasal congestion.

Starco Brands' (OTCQB: STCB) Skylar hypoallergenic fragrance line provides a safe alternative that is hypoallergenic, safe for sensitive skin, cruelty-free, vegan, and without any of the 36 fragrance allergens or 1,300+ "questionable" ingredients found in many perfumes.

Starco Brands Inc. (OTCQB: STCB) is a modern-day invention factory. The company’s unwavering mission is to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday.

This consumer product company has grown from a few million dollars in revenue to a current run rate of approximately $67 million in annual revenue in one year.

The company has succeeded by identifying whitespaces in eight core consumer categories and then either: 1) leveraging its internal R&D capabilities and dedicated manufacturing network to invent new technologies and brands or 2) utilizing the management team’s extensive M&A experience to acquire brands that fill the industry void, delighting consumers and retailers alike.

Whether the brand is developed internally or acquired, the company employs a modern marketing playbook to ensure its brands are at the forefront of culture; garnering unprecedented media attention and engagement that supports a robust sales network.

Starco Brands’ core competencies are inventing technologies, acquiring companies, marketing, building trends, pushing awareness, penetrating media (social and otherwise) and executing cutting edge pull-through strategies with a roster of globally recognized celebrities, influencers and media and distribution partners.

A commitment to changing the way people approach everyday activities is innate in the company’s corporate DNA.

The company is based in Santa Monica, California.


Whereas other consumer products companies are content with evolution, Starco Brands has its mind set on creating a revolution across the industry. From disrupting the spirits industry with Whipshots, the world’s only vodka-infused whipped cream, to Soylent, the original food tech company, Starco Brands is putting the CPG world on notice. Its portfolio of brands includes:

  • Whipshots is a first-of-its-kind alcoholic whipped cream launched in 2021 with celebrity partner Cardi B. Consumers have embraced this boozy concoction, putting it on top of cocktails, coffees and desserts, or enjoying it straight from the can. In just over a year, the brand has sold over 2 MILLION cans, making it one of the fastest growing spirits in history.
  • Winona Pure gives consumers movie theatre popcorn in the comfort of their own homes. All the flavor and none of the additives is the story behind these all-natural, non-GMO popcorn seasoning sprays. A simple spray is all it takes to add the perfect pop of flavor to the classic theatre treat.
  • Art of Sport, co-founded by the great Kobe Bryant, is the number one body care brand for athletes. With a growing line of personal care products tested by the world’s greatest athletes, these daily skin essentials give consumers everything they need to feel fresh, stay protected and confident and perform at their peak every day.
  • Skylar is the first and only line of perfumes on the market that are hypoallergenic and safe for sensitive skin. With the strong support of industry titan Sephora, the brand has quickly attracted a loyal following.
  • Soylent is a technological feat. Originally funded by Google Ventures and Andreessen Horwitz, Soylent is dubbed as the world’s most perfect food. Made from sustainably grown plant-based ingredients, Soylent’s line of products is scientifically developed to provide all the functional ingredients, vitamins, minerals, fats, carbohydrates and protein that the body needs – all in convenient, delicious and affordable packages. Soylent’s innovative product line-up includes complete nutrition powders, ready-to-drink shakes, 100-calorie snack bars, high protein nutrition shakes and energy boosting nutrition shakes. Soylent was also the recipient of the 2023 Product of the Year Award by Kantar, a global leader in consumer research.

With award-winning marketing talent, Starco Brands develops robust, integrated marketing plans for every brand in its portfolio, ensuring an impactful presence across all verticals.

Market Outlook

Starco Brands’ varied brand portfolio gives it access to the growth of numerous product categories that are ripe for innovation.

Through its February 2023 acquisition of complete nutrition pioneer Soylent, Starco Brands is positioned to capitalize on the projected growth of the plant-based nutrition space. Research firm Statista valued the plant-based nutrition market at $29.4 billion in 2020 and forecasts its value at nearly $162 billion by 2030, representing a CAGR of 18.7% for the period.

Likewise, Starco Brands gained improved access to the global fragrance market through its December 2022 acquisition of Skylar. According to a report by Grand View Research, the global perfume market was valued at $50.85 billion in 2022 and is expected to grow to a value of nearly $80 billion by 2030, achieving a CAGR of 5.9% over the forecast period.

The company is primed to expand its access to other growth verticals as it advances on its path to invent and acquire behavior-changing technologies and brands.

Management Team

Ross Sklar is the CEO of Starco Brands. A chemical formulator by trade, he started his first company while still in college. Since 2004, he has made over a dozen acquisitions with multiple exits and controls an eclectic collection of industrial, household, personal care and food and beverage manufacturers covering many consumer-packaged goods categories.

Darin Brown is the Chief Operating Officer of Starco Brands. With over 20 years of experience in chemical manufacturing, business development, finance and mergers and acquisitions, he has scaled the company from the ground up. He oversees all internal operations for Starco Brands and is an integral liaison between the company and Mr. Sklar’s manufacturing facilities.

David Dreyer is Chief Marketing Officer of Starco Brands. With over 25 years of experience working with blue chip and startup brands, he oversees all marketing initiatives for the company. Mr. Dreyer comes to Starco having worked with such standout brands as Apple, Pepsi, Pizza Hut, Dr Pepper, Snapple, Infiniti, The GRAMMY’s, Honda and He is also a Professor of Advertising at USC’s Annenberg School for Communication.

Starco Brands Inc. (STCB), closed Monday's trading session at $0.121, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0725/$0.265.

Recent News

GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

GeoSolar Technologies ("GST"), a Colorado-based climate technology company, has centered its corporate mission around pioneering an approach into clean energy solutions for households. "The company has pioneered the creation of its proprietary SmartGreen(TM) Home system technological solution, designed to address the residential energy use, which drives as much as 20% greenhouse gas (‘GHG') emissions in the United States," a recent article reads. "In its bid to both address U.S. household emissions as well as transform every aspect of the living experience for the better, GeoSolar's proprietary technology seeks to harness the power of the sun and earth to fully electrify homes. From solar panels on roofs and geothermal heat pumps, which harness heat emanating from the earth's core, through to advanced CERV 2 air purification systems designed to manage indoor air quality in an efficient and intelligent manner, the SmartGreen(TM) system has been designed to dramatically increase the energy efficiency of a conventional household. Ultimately, the technology will seek to void the need for a home to depend on carbon-powered utilities or face increasingly exorbitant energy costs subject to volatile fossil fuel commodity prices."

To view the full article, visit

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.


The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.


The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.

Recent News


Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, is partnering with Phenix Truck Bodies & Van Equipment to develop a light-weight truck body for its class 3 EV. One of California's largest providers of work trucks, equipment and specialty truck bodies, Phenix has an impressive list of long-term customers, including Southern California Edison, Southern California Gas, Los Angeles County Fire Department, SDG&E, USDA Forest Service and LA County Department of Public Works. MULN noted that the majority of commercial vehicles sold in the United States are sold through upfitters such as Phenix. The collaboration between the two companies is designed to produce an EV alternative to ICE vehicles, which will be made available to Phenix commercial fleet customers. The Mullen THREE truck has a tight turning diameter of 38 feet and offers excellent visibility for superior maneuverability on narrow city streets. "Phenix, in its 45-year history, has outfitted vehicles for some of the largest commercial public utility customers in the western U.S. with focus on Southern California," said Mullen Automotive CEO and chair David Michery in the press release. "Having the opportunity to add our commercial EVs into the mix with Phenix and their large fleet business is a great step forward for our commercial business."

To view the full press release, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $0.386, off by 10.6481%, on 66,520,507 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.38/$42.75.

Recent News

Data443 Risk Mitigation Inc. (OTC: ATDS)

The QualityStocks Daily Newsletter would like to spotlight Data443 Risk Mitigation Inc. (OTC: ATDS).

Data443 recently announced the acquisition of certain assets from Israeli-based cyber-security firm, Cyren Ltd., previously a company listed on the Nasdaq stock exchange

The deal will see Data443 acquire capabilities within three significant revenue segments: threat intelligence, URL categorization, and email security

The acquisition marks a major milestone, providing Data443 with direct access to customers with previously contracted revenues of approximately $15 million with upside potential

The acquisition follows Data443's First Quarter 2023 results, which saw dramatic increases in revenues (+125% YoY) and gross margins (over a third to 85%), driving a remarkable 184% YoY surge in gross profit

Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company, provides organizations of all sizes with the necessary software and services required to secure their data across devices and databases. Today, with over 10,000 customers across over 100 countries, Data443 enables its client base to prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies through the provision of a broad and comprehensive product suite.

Data443 Risk Mitigation Inc. (OTC: ATDS) is a data security and privacy software company for ALL THINGS DATA SECURITY™. The company is committed to organizing the world’s information by identifying and protecting all sensitive data regardless of location, platform or format.

Data443 provides software and services to enable secure data across devices and databases – at rest and in transit – locally, on a network, or in the cloud. With over 10,000 customers in more than 100 countries, Data443 provides a modern approach to data governance and security. The company’s framework helps customers prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies.

Data443 derives revenue primarily from contracts for subscriptions to access its SaaS platforms, and ancillary services provided in connection with its subscription services. In today’s ever-changing environment with unique and complex requirements for data privacy, governance and hybrid workforces, every organization needs to know where all their data is, who has access to it and how sensitive it is. Data443 provides the tools needed to give companies control over their data processing activities, with capabilities for identifying, reporting and migrating or deleting sensitive data.

The company is headquartered in Research Triangle Park, North Carolina.


Focused on data security with a privacy-forward methodology, the Data443 product suite delivers solutions designed to securely manage data and data privacy needs on-premises, in the cloud and in hybrid environments. Offerings include:

  • Data Identification Manager reduces risk by shining a light on dark data across cloud, on-premises and hybrid environments. From a centralized dashboard, Data Identification Manager provides the ability to automatically inventory all data repositories, classify and tag all data, and enable global search and discovery – all through an agentless deployment.
  • Data Placement Manager quickly and securely transfers sensitive data over any public or private network. Available as an HP Nonstop server-based application and for Windows, Linux or any public cloud provider, Data Placement Manager enables the scheduling, routing, formatting and transfer of business-critical data.
  • Data Archive Manager is an “all information, anywhere” archiving solution designed to handle and manage all types of privacy requests across cloud, on-premises and hybrid environments. With over 15 years operational history and hundreds of clients managing millions of mailboxes, the platform is purpose-built for information archiving, retention and privacy request management.
  • Data Hound™ is a data discovery, classification and capture toolset that enables organizations to perform quick scans, detailed reporting and subsequent data actions based on policy.
  • Ransomware Recovery Manager is the only industry solution that actively recovers the device, operating system and data with a simple reboot. Using patented, proven technology, the product produces 100% effectiveness for the whole device and datasets.
  • Access Control Manager provides user ID and passwordless access to quickly enable trust across an organization’s entire ecosystem. Its unique architecture allows it to leverage multiple distributed authoritative sources to understand and resolve a typical access request – with the ability to enable or deny the action on the fly.
  • Global Privacy Manager provides organizations one comprehensive view, for all privacy requirements, across all enterprise data, all at once. This unmatched visibility into an organization’s data assets ensures that all private and sensitive data can be identified and protected and that enterprises can obey all relevant privacy laws in any jurisdiction.
  • Sensitive Content Manager is a security-centric collaboration service designed to give organizations the tools needed for successful content sharing, collaboration and safe distribution with full enterprise management in mind. With a continuous sync feature, encrypted data is automatically downloaded and updated in real time – regardless of location – ensuring that users have the most accurate data available.

Market Outlook

A report from Allied Market Research estimates that the global data security market was worth about $19 billion in 2021 and is projected to reach a value of $54.23 billion by 2027. That represents a CAGR of more than 18% for the forecast period, making data security one of the hottest areas within IT.

Separately, Fortune Business Insights estimates the global data privacy software market is valued at $2.36 billion in 2022 and projects it will grow to $25.85 billion by 2029. That represents a CAGR of 40.8% over the forecast period.

Management Team

Jason Remillard is President, CEO and Founder of Data443. He is responsible for overseeing global expansion, management, execution and corporate development. With over 25 years in global enterprise and B2C software sales and marketing, he brings deep leadership and technical experience, having spent previous time at Fortune 500 companies such as Deutsche Bank, TD Bank, IBM & Merrill Lynch.

Greg McCraw is CFO at Data443. He has over 25 years of experience helping businesses strengthen their accounting and finance operations. He previously served as Vice President of Finance for a dental services organization active in acquisitions, and, prior to that, he was managing director of a boutique accounting and finance consulting firm advising Fortune 500 clients in pharmaceutical, financial services, and private equity sectors on how to execute on regulatory and compliance solutions.

Bennett Pursell is Data443’s Chief Technology Officer. He has over 20 years of experience in IT architecture, security governance and systems integration. Prior to his role at Data443, he served as Head of Technology Architecture at Moody’s Investor Services and was Vice President and Technical Architect of Cloud Computing at Deutsche Bank, along with a host of technical and project management roles dating back to 2006, after starting his career as a web developer with a few startups and running research labs.

Kirill Kashigin is Chief Software Architect at Data443. He leads the development and quality teams, and serves as technical adviser and subject matter expert, bringing vast technical knowledge on privacy management and data security. Formerly the CTO of FileFacets, he has nearly 20 years in development of high-performance systems and deployment.

Data443 Risk Mitigation Inc. (OTC: ATDS), closed Monday's trading session at $0.0221, off by 19.3431%, on 266,556 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.01815/$6.99.

Recent News

CISO Global, Inc. (NASDAQ: CISO)

The QualityStocks Daily Newsletter would like to spotlight CISO Global, Inc. (NASDAQ: CISO).

CISO Global Inc. (NASDAQ: CISO), a leading provider of global cybersecurity and compliance, was featured in a recent Cantor Fitzgerald equity research report. "Noting that the company is strategically positioned to fill the cybersecurity talent shortage gap, Cantor Research gave CISO an overweight rating and a $2 price target… The equity report noted CISO's significant Q4 growth, including revenue of $14.7 million, up 150.3% year-over-year, ahead of Cantor's estimate of $13.2 million; security managed services growth of 161.8% year-over-year to $12.4 million at a margin of 61.8%; and growth of professional services totaling 102.6% year-over-year to $2.3 million at a margin of 83.2%," a recent article reads. The company "historically bills customers on a monthly basis; however, the company has been selling larger multiyear enterprise contracts in 2022, resulting in a significant acceleration in deferred revenue," Cantor reported. "We expect [CISO Global] to build on its momentum in making headway into larger enterprise customers, and therefore, we anticipate deferred revenue balance to build going forward." Cantor also noted that the cybersecurity talent shortage landscape could be "highly favorable" to CISO.

To view the full article, visit

CISO Global, Inc. (NASDAQ: CISO) is an industry leader in cybersecurity and compliance services. The company leverages an integrated approach to reduce noise and bridge common silos that often limit the effectiveness of cybersecurity programs. Pulling disparate technologies, teams, and vendors together, CISO helps its clients enjoy a simpler and more successful journey to cyber resilience. Since 2019, CISO Global has worked to rapidly expand by acquiring world-class cybersecurity and compliance businesses with top-tier talent who utilize the latest technology to create innovative protection solutions.

The CISO Global workforce is comprised of cybersecurity experts spanning not only global geographies, but also specialties, industries, regulatory frameworks and focus areas. Its team includes audit and compliance specialists, certified forensics experts, ethical hackers, IEEE® certified biometric professionals, security engineers, around-the-clock analysts, and more – all backed by the most respected credentials in the industry. On an ongoing basis, the company works to identify cyber talent that is culturally aligned and that offers operating leverage through both existing customer revenue and relationships.

CISO Global has invested in enterprise solutions and executive talent to integrate its different organizations into an ecosystem that works together to provide complete cybersecurity through cross-pollination of solutions that begin at the network level and extend through technologies, people, policy, and practices. This ecosystem is intended to foster additional growth opportunities and drive overall recurring revenue. Once engaged, the company strives to become trusted advisors for customers’ cybersecurity and compliance demands by providing tailored security solutions based upon their organizational needs.

While cyber resilience requires cycles of continuous improvement, it is a journey that few in the current business and security climate seem to understand. With its deep bench of seasoned experts, CISO Global works to simplify that journey for its growing customer base, straightening out the curves and speeding up the process to resilience along the way.

Cybersecurity is a Culture, Not a Product

Integrating compliance and security, including principles of security by design, CISO Global helps its clients create an organization-wide culture of cybersecurity. Its offerings include audit and compliance, security operations center services, security engineering, virtual Chief Information Security Officer services, incident response, certified forensics, technical assessments and cybersecurity training.

In contrast to the majority of cybersecurity firms that specialize in a specific technology or service, CISO Global seeks to differentiate itself by remaining technology agnostic, focusing on accumulating highly sought-after subject matter experts. CISO Global believes that bringing together a world-class team of technological experts with multi-faceted proficiency in the critical aspects of cybersecurity is key to providing technology agnostic solutions to its clients in a business ecosystem that suffers from a chronic lack of highly skilled professionals.

CISO Global’s goal is to create a culture of security and to help quantify, define and capture a return on investment from information technology and cybersecurity spending. Its end-to-end, holistic process covers every aspect of clients’ cybersecurity and compliance requirements in an effort to promote greater efficiency and strengthen awareness about the integral role of internal team members in the cybersecurity culture of an organization.

As a result of this strategy, CISO Global customers receive an efficient engagement from a single partner that covers a wide range of their needs – addressing challenges more thoroughly and resolving problems more rapidly when compared to working with a host of vendors.

Market Outlook

According to an analysis by the firm Research and Markets, the global managed security services market was valued at $22.45 billion in 2020 and is projected to reach $77.01 billion by 2030, growing at a CAGR of 12.8% through the forecast period.

An expected increase in cybercrime, cost effectiveness of provided solutions and stringent mandatory government regulations aimed at protecting corporate data will drive the global managed security services market for the foreseeable future.

In addition, the documented and growing use of mobile devices in the workplace and the rise in captured and stored digital data serve to fuel market growth. Moreover, growing awareness about the critical nature of data security, the growing importance of e-business and demand for customized services is expected to offer ample opportunities for expansion of the market during the forecast period.

Management Team

David Jemmett is CEO and founder of CISO Global. He has more than 35 years of executive management and technology experience with telecommunications, managed services, and cybersecurity consulting services. He previously held positions as CEO of GenResults, a leading provider of security consulting services and technology solutions, and as CTO and founder at ClearData Networks, a HIPAA-compliant HealthDATA cloud hosting platform.

Dave Bennett is COO at CISO Global. Since 2015, he has served on the President’s STEM Advisory Board of Grand Canyon University. Before joining CISO Global, he served as Chief Product Officer at Experian Health and as Senior Vice President, Product for Gainwell Technologies. He has also held positions as Vice President and Worldwide Head of Build, Healthcare and Life Sciences at DXC Technology, and as EVP, Product and Strategy at Orion Health.

Ashley Devoto is President and Chief Information Security Officer at CISO Global. Over the past 17 years, Devoto has worked with the cybersecurity elite to design, build, and operate world-class cybersecurity programs for large, diverse organizations in both government and commercial enterprises. Prior to joining CISO, Devoto served as CISO for Booz Allen Hamilton, as business information security officer (BISO) at Bank of America, and as a cyberspace operations officer in the United States Air Force.

Deb Smith is CFO at CISO Global. Prior to assuming that position, she was the company’s EVP, Finance and Accounting. She has also served as SVP, Global Accounting at International Cruise and Excursions Inc., and as Chief Accounting Officer for BeyondTrust, an information security software company. She has also held the positions of Corporate Controller at Aspect Software and Assistant Controller at JDA Software.

CISO Global, Inc. (NASDAQ: CISO), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) is focused on improving domestic specialty mineral infrastructure efficiencies to meet surging national demand by North American manufacturers. "The company is working to advance its Ruby Graphite Project (high-quality natural flake and vein), located in Beaverhead County, Montana, and ZigZag Lake Lithium Property, located in Thunder Bay Mining Division, Crescent Lake Area, Ontario. The company is executing a diversified model to capitalize on market opportunities. Late in March, Reflex entered into a subscription agreement and agreed to make a strategic investment in Bio Graphene Solutions Inc. (‘BGS'). BGS is a private nanotechnology company that specializes in the production of high-quality graphene. As part of the strategic investment, Reflex expects to benefit by collaborating with BGS on potential cross-development projects that include exploring downstream applications that complement any graphite material sourced from the company's Ruby Graphite project, which spans about 2,000 acres in the southwestern corner of the state," a recent article reads. "Aligned with market needs, Reflex has a mine-to-market approach, including plans to custom process graphite products to customer specifications by working with carefully selected, best-of-breed, North American mineral processors, each of whom owns and operates world-class, industrial-scale processing facilities."

To view the full article, visit

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.


Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Monday's trading session at $0.28, off by 0.404075%, on 162,703 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.15/$0.765.

Recent News

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

The QualityStocks Daily Newsletter would like to spotlight BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV).

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently published Q1 2023 financial results and provided a business update. "The Q1 2023 results were in line with analysts' expectations. R&D expenses increased about $800,000 from Q1 2022, which BiondVax attributed to the initiation and ramp-up of R&D activities for its innovative nanosized VHH antibody (‘NanoAb') platform. In particular, the company finalized a preclinical proof-of-concept study of its inhaled anti-COVID NanoAb drug, reporting in January that the therapy virtually eliminated the SARS-CoV-2 virus in the lungs of infected hamsters and virtually prevented illness when inhaled prophylactically. These results built on previously announced data indicating the NanoAb treatment led to significantly milder illness and faster recovery among hamsters in the experimental group compared with the control group. Bullish about BiondVax, the analysts at Aegis Capital Corp. continue to recommend shares of the company with a Buy rating and a $70 target price," a recent article reads. "BiondVax boasts unique big pharma competencies, positioning it to bring innovative therapies to market quicker and at lower cost compared to other companies of similar size."

To view the full article, visit

In November 2022,  more than 100,000 Americans were on the organ transplant list eagerly awaiting an organ. But with the United States having just only approximately 20,000 organ donors, a large portion of people on the organ transplant list have to wait for months or even years. Still, the National Organ Procurement and Transplantation Network notes that 2022 was a record year for organ transplants in America, with the number of transplants increasing by 3.7% to 42,887 transplants. Despite last year's performance, the transplant medicine field is still grappling with major issues that are preventing it from functioning at peak efficiency. The shortage of organs is one of the primary problems facing transplant medicine, with hundreds of thousands of Americans currently waiting for an organ and an average of 20 dying every day while still on the waitlist. The challenges standing in the way of successful transplant medicine could be partially alleviated by the advances made in immunotherapy by entities such as BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), since such breakthroughs may increase the success rates patients experience when they receive donor organs.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, BiondVax is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. BiondVax is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, BiondVax has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, BiondVax signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. BiondVax anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of BiondVax’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

BiondVax has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, BiondVax will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. BiondVax anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future BiondVax drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is BiondVax’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Chief Engineer and Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at BiondVax. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at BiondVax. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining BiondVax, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at BiondVax. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to BiondVax through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), closed Monday's trading session at $1.34, off by 0.740741%, on 42,189 volume. The average volume for the last 3 months is 36,972 and the stock's 52-week low/high is $1.30/$13.50.

Recent News

IGC Pharma Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight IGC Pharma Inc. (NYSE American: IGC).

A recent study funded by the federal government highlights the challenges associated with developing a cannabis breathalyzer. The research, conducted by National Institute of Standards and Technology (NIST) and Colorado Boulder University, demonstrates that determining recent marijuana use based on THC levels in breath is highly unreliable due to inconsistencies. The study, published in the "Breath Research" Journal, involved 18 participants from Colorado who consumed retail marijuana with approximately 25% THC. Breath and blood samples were taken 15 minutes before and one hour after smoking marijuana, using a well-equipped white van conveniently parked outside their homes. The analysis was conducted in a laboratory setting, as NIST clarified that it is not currently working on a breathalyzer device. Instead, the agency concentrated on learning more about how to precisely measure THC and other related substances in a breath sample. Only 8 of the 14 individuals who supplied breath samples before and after using marijuana showed the anticipated increase in THC levels. The remaining findings lacked clarity, with three after-use breath samples exhibiting no detectable THC, and the others exhibiting amounts that were comparable to or lower than the baseline. The marijuana industry is still in flux, and much could change at the state and federal level regarding the way in which this substance is regulated. This is because policy often evolves in response to the emerging scientific data about something, and marijuana policy is no different. As society changes its perception towards marijuana, we are seeing many companies such as IGC Pharma Inc. (NYSE American: IGC) seeking to tap the medicinal qualities of cannabis by developing formulations for chronic pain and other indications from compounds extracted from the marijuana plant. These drugs could broaden the options that patients have in the coming years.

IGC Pharma Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule ( As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products ( such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand ( that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.


IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.


The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

IGC Pharma Inc. (NYSE American: IGC), closed Monday's trading session at $0.3, off by 0.332226%, on 64,491 volume. The average volume for the last 3 months is 63,223 and the stock's 52-week low/high is $0.2785/$0.74.

Recent News

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)

The QualityStocks Daily Newsletter would like to spotlight Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF).

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) (the "Company" or "Arizona Metals"), a leading exploration and development company, is pleased to announce the latest drilling results from the Kay Mine Deposit in Arizona . The results from five additional drill holes demonstrate the significant potential of the deposit and highlight the expansion opportunities within the broader property.

Highlights of the recent drilling include:

Hole KM-23-103 intersected 10.5 meters grading 6.2% copper equivalent (CuEq) , including 2.7 meters at 10.5% CuEq and 1.5 meters at 8.9% CuEq . This hole confirms the high-grade copper and gold mineralization previously encountered in hole KM-21-19. Moreover, it extends the mineralization 20 meters north of KM-21-19 and 70 meters north of KM-22-68. The presence of multi-gram gold assays suggests the potential for delineating a high-grade gold zone in the western portion of the Kay Mine Deposit.

Hole KM-23-105 intercepted 7.3 meters grading 4.6% CuEq , (including 2.0 meters at 8.7% CuEq) , starting at a depth of 553.2 meters. Furthermore, at 13.7 meters below, the hole intersected 28.8 meters grading 1.2% CuEq , including 2.3 meters at 5.9% CuEq . This hole confirms the excellent continuity, thickness, and grade of mineralization within a previously unexplored 50-meter gap in the central part of the Kay Mine Deposit.

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine Project, located in Yavapai County. The company also owns Sugarloaf Peak gold project in La Paz County.

The company in October 2022 received permit approval from the Bureau of Land Management (BLM) for two new drill pads, located approximately 1,200 meters west of the Kay Mine Deposit. These new pads will allow for testing of the company’s Western Target, while also allowing for drilling of additional coincident anomalies located between the Central and Western Targets. Construction of the drill road for the Central Target (located 500 meters west of the Kay Mine Deposit) is currently underway, with drilling expected to begin in November 2022. Road construction for the Western Target will begin upon confirmation of BLM acceptance of the company’s posted bond, with drilling expected to commence in Q1 2023.

The company is fully funded, with $60 million in cash as of June 30, 2022, to complete the remaining 18,000 meters planned for the Phase 2 program at Kay, as well as an additional 76,000 meters in the Phase 3 program (budgeted at $27 million), which will be used to test the numerous parallel targets heading west of the Kay Deposit, as well as the northern and southern extensions of the Kay Deposit.

Arizona Metals Corp. is based in Toronto, Canada.


Arizona Metals Corp. owns 100% of the Kay Mine property in Yavapai County, which is located on a combination of patented and BLM claims totaling 1,300 acres that are not subject to any royalties. An historic estimate by Exxon Minerals in 1982 reported a “proven and probable reserve of 6.4 million short tons at a grade of 2.2% copper, 2.8 grams per ton gold, 3.03% zinc, and 55 grams per ton silver.” The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported by Exxon, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a “qualified person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects) before the historic estimate can be verified and upgraded to be a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

The company also owns 100% of the Sugarloaf Peak Property in La Paz County, which is located on 4,400 acres of BLM claims. Sugarloaf is a heap-leach, open-pit target and has a historic estimate of “100 million tons containing 1.5 million ounces (of) gold” at a grade of 0.5 grams per ton. The historic estimate at the Sugarloaf Peak Property was reported by Westworld Resources in 1983. The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a qualified person before the historic estimate can be verified and upgraded to a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, reports that global demand for gold during the first six months of 2022 was 2,189 tons, a 12% increase in demand over the same period in 2021. Demand came primarily from gold bar and coin investors, jewelry consumers, central bank purchases to bolster currency reserves and technology manufacturing.

The average price per ounce for the period was $1,871, marking a 1% year-over-year increase. The council reported gold mine production for the period was up 3% over 2021 at 1,764 tons. For the remainder of 2022 and into 2023, the council projects flat gold demand with possible slight increases in gold mine production. The council notes that unpredictable geopolitical factors, the Ukraine war for example, and likelihood of global economic slowdown could have significant near-term impact on gold demand and prices.

Management Team

Marc Pais is President and CEO of Arizona Metals. He previously founded and served as President of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. He has seven years of experience as a Mining Analyst, with a focus on precious metals development companies. He holds a B.Sc. in Geological Engineering (Mineral Exploration) from Queen’s University in Canada.

David Smith is the Vice President, Exploration of Arizona Metals. He has 30 years of global precious metals exploration experience, including codiscovery of the Solidaridad/La Sabila deposit in Mexico with deposits estimated at 1 million ounces of gold. His core areas of expertise are managing mineral projects from acquisition to exploration, resource modeling and mineral project development. He holds an M.Sc. from the University of Oregon and an MBA from Pinchot University/Presidio Graduate School.

Paul Reid is the Executive Chairman of Arizona Metals. He previously founded and served as Executive Chairman of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. Paul has extensive experience as an Investment Banking professional, involved in raising capital, go-public transactions, and advisory services.

Vision Energy Corp. (OTCQX: AZMCF), closed Monday's trading session at $2.474, off by 0.241935%, on 112,823 volume. The average volume for the last 3 months is 112,723 and the stock's 52-week low/high is $2.30/$4.04.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.